1. Home
  2. AIRI vs NXL Comparison

AIRI vs NXL Comparison

Compare AIRI & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Air Industries Group

AIRI

Air Industries Group

HOLD

Current Price

$3.36

Market Cap

15.8M

Sector

Industrials

ML Signal

HOLD

Logo Nexalin Technology Inc.

NXL

Nexalin Technology Inc.

HOLD

Current Price

$0.59

Market Cap

18.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIRI
NXL
Founded
1979
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.8M
18.6M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
AIRI
NXL
Price
$3.36
$0.59
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
287.5K
177.0K
Earning Date
11-14-2025
03-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$50,031,000.00
$156,931.00
Revenue This Year
N/A
$38.28
Revenue Next Year
$3.53
$185.71
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.77
$0.54
52 Week High
$4.48
$3.87

Technical Indicators

Market Signals
Indicator
AIRI
NXL
Relative Strength Index (RSI) 56.98 34.31
Support Level $3.20 $0.61
Resistance Level $3.41 $0.77
Average True Range (ATR) 0.14 0.05
MACD 0.00 0.00
Stochastic Oscillator 79.41 4.64

Price Performance

Historical Comparison
AIRI
NXL

About AIRI Air Industries Group

Air Industries Group is an aerospace and defense company. Its manufactures and designs structural parts and assemblies that focus on flight safety, including landing gear, arresting gear, engine mounts, flight controls, throttle quadrants, jet engines, and other components. The company also provides sheet metal fabrication of aerostructures, tube bending, and welding services.

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Share on Social Networks: